NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.
Journal
Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
medline:
8
9
2023
pubmed:
7
9
2023
entrez:
6
9
2023
Statut:
ppublish
Résumé
The NCCN Guidelines for Breast Cancer Screening and Diagnosis provide health care providers with a practical, consistent framework for screening and evaluating a spectrum of clinical presentations and breast lesions. The NCCN Breast Cancer Screening and Diagnosis Panel is composed of a multidisciplinary team of experts in the field, including representation from medical oncology, gynecologic oncology, surgical oncology, internal medicine, family practice, preventive medicine, pathology, diagnostic and interventional radiology, as well as patient advocacy. The NCCN Breast Cancer Screening and Diagnosis Panel meets at least annually to review emerging data and comments from reviewers within their institutions to guide updates to existing recommendations. These NCCN Guidelines Insights summarize the panel's decision-making and discussion surrounding the most recent updates to the guideline's screening recommendations.
Identifiants
pubmed: 37673117
doi: 10.6004/jnccn.2023.0046
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM